LaBarre Michael J. 4
4 · HALOZYME THERAPEUTICS, INC. · Filed Feb 24, 2025
Insider Transaction Report
Form 4
LaBarre Michael J.
VP, Product Development
Transactions
- Tax Payment
Common Stock
2025-02-23$57.75/sh−2,410$139,178→ 195,453 total - Exercise/Conversion
Common Stock
2025-02-23+4,747→ 197,863 total - Exercise/Conversion
Restricted Stock Units
2025-02-23−4,747→ 14,238 totalExercise: $0.00→ Common Stock (4,747 underlying)
Footnotes (2)
- [F1]The reported disposition of 2,410 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
- [F2]This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.